Alalawy A, Sakran M, Alzuaibr F, Alotaibi M, El-Hefnawy M, Hazazi A
Sci Rep. 2023; 13(1):22782.
PMID: 38129495
PMC: 10739747.
DOI: 10.1038/s41598-023-49578-0.
Graff B, Palanivel C, Jenkins C, Baranowska-Kortylewicz J, Yan Y
Cell Death Discov. 2023; 9(1):162.
PMID: 37179350
PMC: 10183037.
DOI: 10.1038/s41420-023-01454-6.
Chaudhry G, Md Akim A, Sung Y, Sifzizul T
Front Pharmacol. 2022; 13:842376.
PMID: 36034846
PMC: 9399632.
DOI: 10.3389/fphar.2022.842376.
Wordeman L, Vicente J
Cancers (Basel). 2021; 13(22).
PMID: 34830812
PMC: 8616087.
DOI: 10.3390/cancers13225650.
Lan Y, Chen Y, Liu C, Tung K, Wu Y, Lin S
Oncol Lett. 2021; 22(4):705.
PMID: 34457060
PMC: 8358625.
DOI: 10.3892/ol.2021.12966.
Biophysical and biomechanical properties of neural progenitor cells as indicators of developmental neurotoxicity.
Mahajan G, Lee M, Kothapalli C
Arch Toxicol. 2019; 93(10):2979-2992.
PMID: 31428840
PMC: 6788978.
DOI: 10.1007/s00204-019-02549-9.
Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines.
Effendi W, Nagano T, Tachihara M, Umezawa K, Kiriu T, Dokuni R
Cancer Manag Res. 2019; 11:3669-3679.
PMID: 31118789
PMC: 6500879.
DOI: 10.2147/CMAR.S193789.
Zerumbone, a cyclic sesquiterpene, exerts antimitotic activity in HeLa cells through tubulin binding and exhibits synergistic activity with vinblastine and paclitaxel.
Ashraf S, Sebastian J, Rathinasamy K
Cell Prolif. 2018; 52(2):e12558.
PMID: 30525278
PMC: 6496756.
DOI: 10.1111/cpr.12558.
6mer seed toxicity in tumor suppressive microRNAs.
Gao Q, Putzbach W, Murmann A, Chen S, Sarshad A, Peter J
Nat Commun. 2018; 9(1):4504.
PMID: 30374110
PMC: 6206098.
DOI: 10.1038/s41467-018-06526-1.
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer.
Wahba J, Natoli M, Whilding L, Parente-Pereira A, Jung Y, Zona S
Cancer Immunol Immunother. 2018; 67(11):1753-1765.
PMID: 30167862
PMC: 6208825.
DOI: 10.1007/s00262-018-2199-8.
Tc-Glucarate for assessment of paclitaxel therapy in human ovarian cancer in mice.
Sadeghi H, Rahmanian N, Talebpour Amiri F, Amirfakhrian H, Abedi S, Hosseinimehr S
Iran J Basic Med Sci. 2018; 21(1):77-82.
PMID: 29372040
PMC: 5776440.
DOI: 10.22038/IJBMS.2017.24707.6138.
Investigation of graphene-based nanomaterial as nanocarrier for adsorption of paclitaxel anticancer drug: a molecular dynamics simulation study.
Hasanzade Z, Raissi H
J Mol Model. 2017; 23(2):36.
PMID: 28120117
DOI: 10.1007/s00894-017-3207-1.
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
Thakkar A, Wang B, Picon-Ruiz M, Buchwald P, Ince T
Breast Cancer Res Treat. 2016; 157(1):77-90.
PMID: 27120467
PMC: 4869778.
DOI: 10.1007/s10549-016-3807-y.
High-dose chemotherapeutics of intravesical chemotherapy rapidly induce mitochondrial dysfunction in bladder cancer-derived spheroids.
Yoshida T, Okuyama H, Nakayama M, Endo H, Nonomura N, Nishimura K
Cancer Sci. 2014; 106(1):69-77.
PMID: 25363302
PMC: 4317779.
DOI: 10.1111/cas.12567.
Apoptosis and pro-inflammatory cytokine response of mast cells induced by influenza A viruses.
Liu B, Meng D, Wei T, Zhang S, Hu Y, Wang M
PLoS One. 2014; 9(6):e100109.
PMID: 24923273
PMC: 4055757.
DOI: 10.1371/journal.pone.0100109.
Isolation of anticancer drug TAXOL from Pestalotiopsis breviseta with apoptosis and B-Cell lymphoma protein docking studies.
Kathiravan G, Sureban S, Sree H, Bhuvaneshwari V, Kramony E
J Basic Clin Pharm. 2014; 4(1):14-9.
PMID: 24808664
PMC: 3894731.
DOI: 10.4103/0976-0105.109402.
Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
Wang H, Vo T, Hajar A, Li S, Chen X, Parissenti A
BMC Cancer. 2014; 14:37.
PMID: 24447372
PMC: 3900991.
DOI: 10.1186/1471-2407-14-37.
Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, decline in ATP levels, and VDAC.
Dinnen R, Mao Y, Qiu W, Cassai N, Slavkovich V, Nichols G
Mol Cancer Ther. 2013; 12(12):2792-803.
PMID: 24126434
PMC: 4318573.
DOI: 10.1158/1535-7163.MCT-13-0234.
Cytokines as biomarkers of nanoparticle immunotoxicity.
Elsabahy M, Wooley K
Chem Soc Rev. 2013; 42(12):5552-76.
PMID: 23549679
PMC: 3665642.
DOI: 10.1039/c3cs60064e.
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer.
Martin M, Prat A, Rodriguez-Lescure A, Caballero R, Ebbert M, Munarriz B
Breast Cancer Res Treat. 2013; 138(2):457-66.
PMID: 23423445
PMC: 3608881.
DOI: 10.1007/s10549-013-2416-2.